Matches in SemOpenAlex for { <https://semopenalex.org/work/W141837990> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W141837990 endingPage "5" @default.
- W141837990 startingPage "142" @default.
- W141837990 abstract "The long elimination half-lives of fluoxetine and norfluoxetine, the active metabolite of fluoxetine, are of potential consequence when alternative antidepressant agents are introduced after the termination of fluoxetine therapy. It is not known whether paroxetine, an antidepressant agent in the same pharmacologic class as fluoxetine, can be substituted for fluoxetine without the need for an intervening washout period. The objective of this trial was to assess the tolerability of an immediate switch from fluoxetine to paroxetine therapy.Patients who were treated for moderate to moderately severe major depressive disorder (DSM-III-R 296.2 or 296.3) with a stable dose of fluoxetine for a minimum of 6 weeks' duration were randomized in a double-blind fashion to one of two treatment groups. One group (N = 123) was started on 20 mg of paroxetine daily the morning after their last dose of fluoxetine, and the other group (N = 119) was started on 20 mg of paroxetine daily following a 2-week placebo-washout period. Patient visits were scheduled at weekly intervals for a total of 4 weeks. Adverse experience monitoring was conducted at each visit.There was no difference in the proportion of patients who discontinued prematurely from the trial due to an adverse experience. Eight patients in the immediate-switch group and 6 patients in the placebo-washout group withdrew from the trial in response to an adverse experience (p = .63, chi-square). The overall profile of adverse experiences was similar in the two treatment groups over the 4-week period. The incidence of adverse experiences in the first 2 weeks following the initiation of paroxetine was generally lower in the group with the intervening 2-week placebo-washout period.The immediate switch from fluoxetine to paroxetine was as well tolerated as the switch to paroxetine after a 2-week placebo-washout period." @default.
- W141837990 created "2016-06-24" @default.
- W141837990 creator A5051186493 @default.
- W141837990 creator A5054576571 @default.
- W141837990 creator A5057973038 @default.
- W141837990 creator A5059514843 @default.
- W141837990 date "1995-04-01" @default.
- W141837990 modified "2023-09-23" @default.
- W141837990 title "A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period." @default.
- W141837990 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7713852" @default.
- W141837990 hasPublicationYear "1995" @default.
- W141837990 type Work @default.
- W141837990 sameAs 141837990 @default.
- W141837990 citedByCount "6" @default.
- W141837990 crossrefType "journal-article" @default.
- W141837990 hasAuthorship W141837990A5051186493 @default.
- W141837990 hasAuthorship W141837990A5054576571 @default.
- W141837990 hasAuthorship W141837990A5057973038 @default.
- W141837990 hasAuthorship W141837990A5059514843 @default.
- W141837990 hasConcept C126322002 @default.
- W141837990 hasConcept C142724271 @default.
- W141837990 hasConcept C15744967 @default.
- W141837990 hasConcept C168563851 @default.
- W141837990 hasConcept C170493617 @default.
- W141837990 hasConcept C197934379 @default.
- W141837990 hasConcept C204787440 @default.
- W141837990 hasConcept C27081682 @default.
- W141837990 hasConcept C2775864247 @default.
- W141837990 hasConcept C2776134451 @default.
- W141837990 hasConcept C2777828372 @default.
- W141837990 hasConcept C2778375690 @default.
- W141837990 hasConcept C2779144063 @default.
- W141837990 hasConcept C2779177272 @default.
- W141837990 hasConcept C2780051608 @default.
- W141837990 hasConcept C2781161787 @default.
- W141837990 hasConcept C31487548 @default.
- W141837990 hasConcept C42219234 @default.
- W141837990 hasConcept C71924100 @default.
- W141837990 hasConceptScore W141837990C126322002 @default.
- W141837990 hasConceptScore W141837990C142724271 @default.
- W141837990 hasConceptScore W141837990C15744967 @default.
- W141837990 hasConceptScore W141837990C168563851 @default.
- W141837990 hasConceptScore W141837990C170493617 @default.
- W141837990 hasConceptScore W141837990C197934379 @default.
- W141837990 hasConceptScore W141837990C204787440 @default.
- W141837990 hasConceptScore W141837990C27081682 @default.
- W141837990 hasConceptScore W141837990C2775864247 @default.
- W141837990 hasConceptScore W141837990C2776134451 @default.
- W141837990 hasConceptScore W141837990C2777828372 @default.
- W141837990 hasConceptScore W141837990C2778375690 @default.
- W141837990 hasConceptScore W141837990C2779144063 @default.
- W141837990 hasConceptScore W141837990C2779177272 @default.
- W141837990 hasConceptScore W141837990C2780051608 @default.
- W141837990 hasConceptScore W141837990C2781161787 @default.
- W141837990 hasConceptScore W141837990C31487548 @default.
- W141837990 hasConceptScore W141837990C42219234 @default.
- W141837990 hasConceptScore W141837990C71924100 @default.
- W141837990 hasIssue "4" @default.
- W141837990 hasLocation W1418379901 @default.
- W141837990 hasOpenAccess W141837990 @default.
- W141837990 hasPrimaryLocation W1418379901 @default.
- W141837990 hasRelatedWork W137885780 @default.
- W141837990 hasRelatedWork W141837990 @default.
- W141837990 hasRelatedWork W1645763 @default.
- W141837990 hasRelatedWork W1966381163 @default.
- W141837990 hasRelatedWork W1976841336 @default.
- W141837990 hasRelatedWork W2018067258 @default.
- W141837990 hasRelatedWork W2082346425 @default.
- W141837990 hasRelatedWork W2397540649 @default.
- W141837990 hasRelatedWork W2434487065 @default.
- W141837990 hasRelatedWork W142470226 @default.
- W141837990 hasVolume "56" @default.
- W141837990 isParatext "false" @default.
- W141837990 isRetracted "false" @default.
- W141837990 magId "141837990" @default.
- W141837990 workType "article" @default.